Affiliation:
1. Department of Oncology, University of Alberta, Cross Cancer Institute, Edmonton, Alberta T6G 1Z2, Canada
Abstract
Aim: To explore factors affecting coronavirus disease 2019 (COVID-19) mortality among cancer patients based on a pharmacovigilance database. Methods: US FDA Adverse Event Reporting System (FAERS) quarterly data extract files were reviewed for quarters two, three and four of 2020 (i.e., April to December). Patients with an indication related to malignancy and a reported COVID-related reaction were selected. Multivariate logistic regression analysis for factors associated with a fatal outcome was conducted. Results: A total of 2708 patients were included. The following factors were associated with fatal COVID-19 infection: older age (odds ratio [OR]: 1.03; 95% CI: 1.01–1.04), male sex (OR: 1.43; 95% CI: 1.07–1.91), non-US report source (OR: 2.46; 95% CI: 1.93–3.13), hematological malignancy (OR: 1.62; 95% CI: 1.28–2.07), potentially immunosuppressive treatment (OR: 1.83; 95% CI: 1.30–2.58) and diagnosis in quarter two versus quarter four (OR: 1.62; 95% CI: 1.27–2.07). Conclusion: Within FAERS reports, cancer patients who are older, males and receiving immunosuppressive treatment and those with hematological malignancies were at a higher risk of death because of COVID-19 infection.
Subject
Cancer Research,Oncology,General Medicine
Cited by
3 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献